Nanomedicine: Nanotechnology, Biology and Medicine
Volume 3, Issue 3 , Pages 173-183 , September 2007

Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides

  • Noha Nafee, PharmD

      Affiliations

    • Biopharmaceutics and Pharmaceutical Technology, Saarland University, Saarbrücken, Germany
    • Faculty of Pharmacy, Department of Pharmaceutics, University of Alexandria, Alexandria, Egypt
    • ,
  • Sebastian Taetz, PharmD

      Affiliations

    • Biopharmaceutics and Pharmaceutical Technology, Saarland University, Saarbrücken, Germany
    • ,
  • Marc Schneider, PhD

      Affiliations

    • Biopharmaceutics and Pharmaceutical Technology, Saarland University, Saarbrücken, Germany
    • Corresponding Author InformationCorresponding author. Biopharmaceutics and Pharmaceutical Technology, Saarland University, Campus Saarbruücken, Bldg. A41, P.O. Box 151150, 66041 Saarbrücken, Germany
    • ,
  • Ulrich F. Schaefer, PhD

      Affiliations

    • Biopharmaceutics and Pharmaceutical Technology, Saarland University, Saarbrücken, Germany
    • ,
  • Claus-Michael Lehr, PhD

      Affiliations

    • Biopharmaceutics and Pharmaceutical Technology, Saarland University, Saarbrücken, Germany

Received 22 January 2007 ,Accepted 15 March 2007.

References 

  1. Brewster LP, Brey EM, Greisler HP. Cardiovascular gene delivery: the good road is awaiting. Adv Drug Deliv Rev. 2006;58:604–629
  2. Kofron MD, Laurencin CT. Bone tissue engineering by gene delivery. Adv Drug Deliv Rev. 2006;58:555–576
  3. Qian Y, Mugiira RB, Zhou X. A modified viral satellite DNA-based gene silencing vector is effective in association with heterologous begomoviruses. Virus Res. 2006;118:136–142
  4. Sen L, Gambhir SS, Furukawa H, Stout DB, Linh Lam A, Laks H, et al. Noninvasive imaging of ex vivo intracoronarily delivered nonviral therapeutic transgene expression in heart. Mol Ther. 2005;12:49–57
  5. Hama S, Akita H, Ito R, Mizuguchi H, Hayakawa T, Harashima H. Quantitative comparison of intracellular trafficking and nuclear transcription between adenoviral and lipoplex systems. Mol Ther. 2006;13:786–794
  6. Lim MJ, Min S-H, Lee J-J, Kim IC, Kim JT, Lee DC, et al. Targeted therapy of DNA tumor virus-associated cancers using virus-activated transcription factors. Mol Ther. 2006;13:899–909
  7. Li S, Huang L. Nonviral gene therapy: promises and challenges. Gene Ther. 2000;7:31–34
  8. Zhang C, Tang N, Liu X, Liang W, Xu W, Torchilin VP. siRNA-containing liposomes modified with polyarginine effectively silence the targeted gene. J Control Release. 2006;112:229–239
  9. Ishida T, Harada M, Wang XY, Ichihara M, Irimura K, Kiwada H. Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes. J Control Release. 2005;105:305–317
  10. Kim TH, Kim SI, Akaike T, Cho CS. Synergistic effect of poly(ethylenimine) on the transfection efficiency of galactosylated chitosan/DNA complexes. J Control Release. 2005;105:354–366
  11. Park MR, Han KO, Han IK, Cho MH, Nah JW, Choi YJ, et al. Degradable polyethylenimine-alt-poly(ethylene glycol) copolymers as novel gene carriers. J Control Release. 2005;105:367–380
  12. Köping-Höggard M, Varum KM, Issa M, Danielsen S, Christensen BE, Stokke BT, et al. Improved chitosan-mediated gene delivery based on easily dissociated chitosan polyplexes of highly defined chitosan oligomers. Gene Ther. 2004;11:1441–1452
  13. Sanchez A, Tobio M, Gonzalez L, Fabra A, Alonso MJ. Biodegradable micro- and nanoparticles as long-term delivery vehicles for interferon-α. Eur J Pharm Sci. 2003;18:221–229
  14. Shakweh M, Besnard M, Nicolas V, Fattal E. Poly(lactide-co-glycolide) particles of different physicochemical properties and their uptake by Peyer's patches in mice. Eur J Pharm Biopharm. 2005;61:1–13
  15. Song CX, Labhasetwar V, Murphy H, Qu X, Humphrey WR, Shebuski RJ, et al. Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery. J Control Release. 1997;43:197–212
  16. Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev. 2004;56:1649–1659
  17. Ribeiro S, Hussain N, Florence AT. Release of DNA from dendriplexes encapsulated in PLGA nanoparticles. Selected contributions from the 5th European Workshop on Particulate Systems. Int J Pharm. 2005;298:354–360
  18. Cegnar M, Premzl A, Zavasnik-Bergant V, Kristl J, Kos J. Poly(lactide-co-glycolide) nanoparticles as a carrier system for delivering cysteine protease inhibitor cystatin into tumor cells. Exp Cell Res. 2004;301:223–231
  19. Panyam J, Dali MM, Sahoo SL, Ma W, Chakravarthi SS, Amidon GL, et al. Polymer degradation and in vitro release of a model protein from poly(d,l-lactide-co-glycolide) nano- and microparticles. J Control Release. 2003;92:173–187
  20. Chorny M, Fishbein I, Danenberg HD, Golomb G. Lipophilic drug loaded nanospheres prepared by nanoprecipitation: effect of formulation variables on size, drug recovery and release kinetics. J Control Release. 2002;83:389–400
  21. Costantino L, Gandolfi F, Bossy-Nobs L, Tosi G, Gurny R, Rivasi F, et al. Nanoparticulate drug carriers based on hybrid poly(d,l-lactide-co-glycolide)-dendron structures. Biomaterials. 2006;27:4635–4645
  22. Elkharraz K, Faisant N, Guse C, Siepmann F, Arica-Yegin B, Oger JM, et al. Paclitaxel-loaded microparticles and implants for the treatment of brain cancer: preparation and physicochemical characterization. Int J Pharm. 2006;314:127–136
  23. Lamprecht A, Ubrich N, Yamamoto H, Schäfer U, Takeuchi H, Maincent P, et al. Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease. J Pharmacol Exp Ther. 2001;299:775–781
  24. Csaba N, Sanchez A, Alonso MJ. PLGA:poloxamer and PLGA:Poloxamine blend nanostructures as carriers for nasal gene delivery. J Control Release. 2006;113:164–172
  25. Dillen K, Weyenberg W, Vandervoort J, Ludwig A. The influence of the use of viscosifying agents as dispersion media on the drug release properties from PLGA nanoparticles. Eur J Pharm Biopharm. 2004;58:539–549
  26. Trimaille T, Pichot C, Delair T. Surface functionalization of poly(d,l-lactic acid) nanoparticles with poly(ethylenimine) and plasmid DNA by the layer-by-layer approach. Colloids Surf A Physicochem Eng Asp. 2003;221:39–48
  27. Singh M, Ugozzoli M, Briones M, Kazzaz J, Soenawan E, O'Hagan DT. The effect of CTAB concentration in cationic PLG microparticles on DNA absorption and in vivo performance. Pharm Res. 2003;20:247–251
  28. Munier S, Messai I, Delair T, Verrier B, Ataman-Onal Y. Cationic PLA nanoparticles for DNA delivery: comparison of three surface polycations for DNA binding, protection and transfection properties. Colloids Surf B Biointerfaces. 2005;43:163–173
  29. Kwon H-Y, Lee J-Y, Choi S-W, Jang Y, Kim J-H. Preparation of PLGA nanoparticles containing estrogen by emulsification-diffusion method. Colloids Surf A Physicochem Eng Asp. 2001;182:123–130
  30. Ravi Kumar MNV, Bakowsky U, Lehr CM. Preparation and characterization of cationic PLGA nanospheres as DNA carriers. Biomaterials. 2004;25:1771–1777
  31. Dodane V, Amin Khan M, Merwin JR. Effect of chitosan on epithelial permeability and structure. Int J Pharm. 1999;182:21–32
  32. Janes K, Calvo P, Alonso M. Polysaccharide colloidal particles as delivery systems for macromolecules. Adv Drug Deliv Rev. 2001;47:83–97
  33. Ravi Kumar MNV, Mohapatra SS, Kong X, Jena PK, Bakowsky U, Lehr C-M. Cationic poly(lactide-co-glycolide) nanoparticles as efficient in vivo gene transfection agents. J Nanosci Nanotechnol. 2004;4:1–5
  34. Prabha S, Zhou W-Z, Panyam J, Labhasetwar V. Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles. Int J Pharm. 2002;244:105–115
  35. Pitts AE, Corey DR. Inhibition of human telomerase by 2′-O-methyl-RNA. Proc Natl Acad Sci U S A. 1998;95:11549–11554
  36. Song C, Labhasetwar V, Cui X, Underwood T, Levy RJ. Arterial uptake of biodegradable nanoparticles for intravascular local drug delivery: results with an acute dog model. J Control Release. 1998;54:201–211
  37. Mainardes RM, Evangelista RC. PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution. Int J Pharm. 2005;290:137–144
  38. Ikada Y, Tsuji H. Biodegradable polyesters for medical and ecological applications. Macromol Rapid Commun 2000;21:117-32.
  39. Middleton JC, Tipton AJ. Synthetic biodegradable polymers as medical devices. Med Plast Biomater. 1998;5:30–39
  40. Dillen K, Vandervoort J, Ludwig A. Factorial design, physicochemical characterisation and activity of ciprofloxacin-loaded PLGA nanoparticles for ocular use. J Control Release. 2005;101:369–370
  41. Prego C, Garcia M, Torres D, Alonso MJ. Transmucosal macromolecular drug delivery. Proceedings of the Eighth European Symposium on Controlled Drug Delivery. J Control Release. 2005;101:151–162
  42. Sahoo SK, Panyam J, Prabha S, Labhasetwar V. Residual polyvinyl alcohol associated with poly (d,l-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Control Release. 2002;82:105–114
  43. Zambaux MF, Bonneaux F, Gref R, Maincent P, Dellacherie E, Alonso MJ, et al. Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method. J Control Release. 1998;50:31–40
  44. Vandervoort J, Yoncheva K, Ludwig A. Influence of the homogenisation procedure on the physicochemical properties of PLGA nanoparticles. Chem Pharm Bull. 2004;52:1273–1279
  45. Gan Q, Wang T, Cochrane C, McCarron P. Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery. Colloids Surf B Biointerfaces. 2005;44:65–73

 No conflict of interest was reported by the authors of this paper.

PII: S1549-9634(07)00089-5

doi: 10.1016/j.nano.2007.03.006

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 3, Issue 3 , Pages 173-183 , September 2007

Article Tools

* Image Usage & Resolution